Greater than 3,000 prescriptions have been written for Novo’s GLP-1 capsule in its first week available on the market. Elsewhere, Emergent reached a settlement over a buying and selling scandal and Sanofi is reportedly circling a watch drug biotech.
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a worldwide community of future-focused thinkers.
Unlock tomorrow’s developments as we speak: learn extra, subscribe to our e-newsletter, and change into a part of the NextTech neighborhood at NextTech-news.com
